Nav: Home

Minisensor is designed to warn of epileptic seizures

April 07, 2016

For epilepsy patients and attending physicians, it has been a challenge to correctly assess the frequency and severity of epileptic seizures without inpatient recording equipment. A consortium coordinated by the epileptologists of the University Hospital Bonn is now developing a mobile sensor that can detect seizures. A warning signal is designed to summon relatives or attending physicians to provide timely help. The project "EPItect" will receive about two million Euro in subsidies from the German Federal Ministry of Research (BMBF) over the next three years. 635,000 Euro will go to Bonn. In carrying out the ambitious undertaking, the consortium will receive support from the project sponsor VDI/VDE Innovation + Technik GmbH.

Epileptic seizures can take very different courses: Some of those affected smack their lips; others engage in unmotivated fumbling with their clothing; others "go out" completely for a short time; and some actually suffer the muscular twitching that is considered typical. "It is not easy to classify all the symptoms correctly", says Prof. Dr. Christian E. Elger, Director of the Department of Epileptology of the University Hospital Bonn. Some of the seizures even occur during sleep; those affected often don't notice anything at all. "We estimate that the patients consciously perceive a maximum of half their seizures", adds Private Docent Dr. Rainer Surges, lead consultant at the Department of Epileptology at the University Hospital Bonn and coordinator of the joint project.

This subjective misperception of the frequency and strength of seizures impedes both the diagnosis and treatment of epilepsy. The "thunderstorms in the brain" can usually be recorded clearly using electroencephalography, but that requires a hospital stay. "Mobile measuring devices could be integrated much better into the everyday activities of patients", says Dr. Surges. Just such a mobile miniature sensor system is currently under development by a consortium led by the Department of Epileptology of the University Hospital Bonn. The project "EPItect" will receive about two million Euro in subsidies from the German Federal Ministry of Research (BMBF) over the next three years, including 635,000 Euro for the Bonn Hospital.

Minisensor measures symptoms in the ear

The company Cosinuss GmbH in Munich has already developed an epilepsy sensor, which is placed in the ear like a hearing aid. The measuring device will be miniaturized even further and optimized for this purpose. "In a preliminary study sponsored by the Marga and Walter Boll Foundation, we found that epileptic seizures can be detected very well via an accelerated pulse and certain patterns of movement", reports Dr. Surges. These symptoms can be measured by the little ear bud. It is designed to transmit the signals via a connected smartphone to a central computer that continuously checks the incoming data for abnormalities and to warn patients, relatives, and attending physicians if necessary. This is because, in the worst case, epileptic seizures can end in death, for instance due to serious accidents with fatal injuries or due to cardiac arrest in the so-called sudden unexpected death in epilepsy.

More autonomy and easier care for patients

The focus of the project is to develop such automated data and alarm chains and to test and optimize them together with epilepsy patients, relatives, and caregivers. EPItect is designed to make the lives of patients easier and provide assistance in many ways: "Epilepsy patients are often afraid of unpredictable seizures in public", reports Dr. Surges. They can be expected to regain more autonomy, if they can better estimate the current risk of a seizure. Relatives do not have to be afraid that patients will not get care if a new seizure occurs, because a doctor could be called automatically. And the signals of the in-ear sensor give scientists much more reliable data. "With EPItect we can expect to make better diagnoses, because the frequency and severity of seizures can be recorded better", says Prof. Elger. The same goes for the development of new therapies: In clinical studies, the mobile mini-sensor can be used to provide more reliable data, for example regarding the drug that reduces the seizures most effectively.

The EPItect project includes not only adults but also younger patients. "Since many children and adolescents also suffer from epilepsy, we hope to achieve important progress for this target group using the sensor system", says Prof. Dr. Ulrich Stephani, Director of the Department of Neuropediatrics at the Schleswig-Holstein University Hospital in Kiel. The consortium plans to have the new technology available for patients and clinical trials in a few years. In the first step, a study will be done with selected patients. Later EPItect will be made available to a broader group of patients. "In epileptology we are just at the beginning of a breakthrough in mobile healthcare technologies and telemedicine", says Dr. Surges.

The partners in the EPItect consortium

The EPItect consortium consists of five institutions and two associated partners in Germany: Department of Epileptology at the University Hospital Bonn, Fraunhofer Institute for Software and Systems Technology ISST, Department of Neuropediatrics of the University of Kiel (UKSH), the North German Epilepsy Center in Schwentinental-Raisdorf, Cosinuss GmbH Munich, the University for Healthcare Professions in Bochum, and the Epilepsy Bundes-Elternverband e.V. [National Epilepsy Parents Network] in Wuppertal.
-end-
Contact for the media:

Private Docent Dr. med. Rainer Surges
Department of Epileptology
University of Bonn Medical Center
Tel. ++49-228-28714778
E-Mail: Rainer.Surges@ukb.uni-bonn.de

University of Bonn

Related Epilepsy Articles:

Good news for kids with epilepsy
There's good news for kids with epilepsy. While several new drugs have come out in the last several years for adults with epilepsy, making those drugs available for children and teenagers has been delayed due to the challenges of testing new drugs on children.
People with epilepsy: Tell us about rare risk of death
People with epilepsy want their health care providers to tell them about a rare risk of death associated with the disorder, according to a preliminary study released today that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.
New epilepsy gene network identified by scientists
Scientists have discovered a gene network in the brain associated with epilepsy.
Epilepsy -- why do seizures sometimes continue after surgery?
New research from the University of Liverpool, published in the journal Brain, has highlighted the potential reasons why many patients with severe epilepsy still continue to experience seizures even after surgery.
Redox biomarker could predict progression of epilepsy
Approximately 2.9 million people in the United States suffer from epilepsy, according to the CDC.
More Epilepsy News and Epilepsy Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...